GlassScriptPhysician profile
Jeremy Derickson
NPI 1821544503
$6,973.13
in general payments reported to CMS, 2019-2025
48 companies · $1,191 in 2025
The $1,191 reported for 2025 was more than what 86% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,445 · 2022: $1,319 · 2023: $1,650 · 2024: $1,369 · 2025: $1,191.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,195 · Entertainment: $14.63.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,195.27 |
| Entertainment | $14.63 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $1,108.28 | 2021-2025 | Ozempic, Rybelsus, Wegovy |
| Astrazeneca Pharmaceuticals LP | $923.81 | 2021-2025 | Airsupra, Farxiga, Breztri |
| Glaxosmithkline, LLC. | $630.75 | 2021-2025 | Trelegy Ellipta, Shingrix |
| Lilly USA, LLC | $461.16 | 2021-2025 | Jardiance, Mounjaro, Kisunla |
| Boehringer Ingelheim Pharmaceuticals, INC. | $427.58 | 2021-2025 | Jardiance |
| Abbott Laboratories | $310.95 | 2022-2025 | Freestyle Libre 3, Freestyle Libre 2, Proclaim |
| Abbvie INC. | $300.94 | 2021-2025 | |
| Novartis Pharmaceuticals Corporation | $264.97 | 2021-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $230.02 | 2021-2025 | |
| Vanda Pharmaceuticals INC. | $212.75 | 2021-2023 | Hetlioz |
| Merck Sharp & Dohme LLC | $161.76 | 2021-2024 | Belsomra, Gardasil 9, Capvaxive |
| Otsuka America Pharmaceutical, INC. | $144.21 | 2023-2024 | Rexulti |
| Janssen Pharmaceuticals, INC | $143.56 | 2021-2024 | Xarelto |
| Corcept Therapeutics | $137.80 | 2023-2025 | Korlym |
| Eisai INC. | $137.21 | 2021-2022 |
Show all 48 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jeremy Derickson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.